Skip to Content
  • Previous Rank
    132
  • Revenues ($M)
    $22,871.30
  • Revenue Percent Change
    7.8%
  • Profits ($M)
    $-204.1
  • Profits Percent Change
    -107.5%
  • Assets ($M)
    $44,981.00
  • Employees
    40,655
  • Market Value — as of March 29, 2018 ($M)
    $84,542.20

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
David A. Ricks
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Indianapolis
Websitehttp://www.lilly.com
Years on Fortune 500 List24
Employees40,655

Eli Lilly Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,871.307.8%
Profits ($M)$-204.1-107.5%
Assets ($M)$44,981.00-
Total Stockholder Equity ($M)$11,592.20-
Market Value — as of March 29, 2018 ($M)$84,542.20-

Profit Ratios

Profit as % of Revenues-0.9%
Profits as % of Assets-0.5%
Profits as % of Stockholder Equity-1.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)-0.19
EPS % Change (from 2016)-107.4%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2017)17.7%
Total Return to Investors (5 year, annualized)14.7%
Total Return to Investors (10 year, annualized)9%